BioSpace News Archive

Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. GMT ) on Wednesday, Feb. 16, 2022 to discuss the company’s fourth quarter and year-end 2021 financial results.

BioMarin Pharmaceutical Inc. announced that the Company will be presenting data in several presentations on valoctocogene roxaparvovec, an investigational gene therapy for the treatment of adults with severe hemophilia A at the 15th Annual Virtual Congress of the European Association for Haemophilia and Allied Disorders February 2-4.

Viking Therapeutics, Inc. announced today that the company will release financial results for the fourth quarter and year-end 2021, after the market close on Wednesday, February 9, 2022.

A kidney infection, also known as pyelonephritis, is a type of urinary tract infection, wherein one or both kidneys are infected.

Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients.

Hypereosinophilic syndrome is associated with a very high count of eosinophil in the blood. Eosinophils are a type of white blood cells and constitute a very important part of the immune system.

Cellulitis is one of the common skin infections caused by bacteria; mostly streptococcus sp. and staphylococcus sp.

The regulatory preclinical program with Tumorad® (177Lu-SN201) were completed and show a good safety margin for clinically relevant doses.

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the fourth quarter and full year ended December 31, 2021.

Theravance Biopharma, Inc. will present at the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, at 3:40 pm ET.